Does Pfizer Have a Bright Future?
T = Trends for a Stock’s Movement
Pfizer is a biopharmaceutical company that discovers, develops, manufactures, and sells medicines for people and animals worldwide. The company manages its operations through five segments: Primary Care, Specialty Care and Oncology, Established Products and Emerging Markets, Animal Health and Consumer Healthcare, and Nutrition. Pfizer’s main products include human and animal biologic and small molecule medicines, as well as vaccines, nutritional products, consumer healthcare products, and products for the prevention and treatment of diseases in livestock and companion animals.
The U.S. Supreme Court on Monday rejected an appeal from Pfizer, leaving in place a $142 million settlement the pharmaceutical company must pay to the Kaiser Foundation on the grounds that Pfizer falsely marketed an epilepsy drug called Neurontin. The Supreme Court is also allowing two other lawsuits on the same issue to continue forward, according to a report from Bloomberg. Pfizer allegedly marketed the drug as a treatment for migraines, manic-depressive issues, and neuropathic pain when it was not approved by the Food and Drug Administration for those uses.